COVID-19-associated fungal infections

M Hoenigl, D Seidel, R Sprute, C Cunha… - Nature …, 2022 - nature.com
Abstract Coronavirus disease 2019 (COVID-19)-associated invasive fungal infections are an
important complication in a substantial number of critically ill, hospitalized patients with …

Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance

P Koehler, M Bassetti, A Chakrabarti… - The Lancet Infectious …, 2021 - thelancet.com
Severe acute respiratory syndrome coronavirus 2 causes direct damage to the airway
epithelium, enabling aspergillus invasion. Reports of COVID-19-associated pulmonary …

Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum

S Sharma, M Grover, S Bhargava… - The Journal of …, 2021 - cambridge.org
ObjectiveTo study the possible association between invasive fungal sinusitis
(mucormycosis) and coronavirus disease. MethodsA prospective observational study was …

Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: a systematic review and meta-analysis

JS Musuuza, L Watson, V Parmasad… - PloS one, 2021 - journals.plos.org
Introduction The recovery of other pathogens in patients with SARS-CoV-2 infection has
been reported, either at the time of a SARS-CoV-2 infection diagnosis (co-infection) or …

[HTML][HTML] Rhino-orbital mucormycosis associated with COVID-19

S Mehta, A Pandey - Cureus, 2020 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19) infections may be associated with a wide
range of bacterial and fungal co-infections. We report the case of a patient with COVID-19 …

SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance

R Robinot, M Hubert, GD de Melo, F Lazarini… - Nature …, 2021 - nature.com
Understanding how SARS-CoV-2 spreads within the respiratory tract is important to define
the parameters controlling the severity of COVID-19. Here we examine the functional and …

[HTML][HTML] Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European …

J Prattes, J Wauters, DR Giacobbe… - Clinical Microbiology …, 2022 - Elsevier
Abstract Objectives Coronavirus disease 2019 (COVID-19)-associated pulmonary
aspergillosis (CAPA) has emerged as a complication in critically ill COVID-19 patients. The …

COVID-19-associated candidiasis (CAC): an underestimated complication in the absence of immunological predispositions?

A Arastehfar, A Carvalho, MH Nguyen, MT Hedayati… - Journal of fungi, 2020 - mdpi.com
The recent global pandemic of COVID-19 has predisposed a relatively high number of
patients to acute respiratory distress syndrome (ARDS), which carries a risk of developing …

Mucormycosis in patients with COVID‐19: a cross‐sectional descriptive multicentre study from Iran

F Pakdel, K Ahmadikia, M Salehi, A Tabari, R Jafari… - Mycoses, 2021 - Wiley Online Library
Purpose The aim of the study was to report clinical features, contributing factors and
outcome of patients with coronavirus disease 2019 (COVID‐19)‐associated mucormycosis …

[HTML][HTML] Aspergillosis complicating severe coronavirus disease

KA Marr, A Platt, JA Tornheim, SX Zhang… - Emerging infectious …, 2021 - ncbi.nlm.nih.gov
Aspergillosis complicating severe influenza infection has been increasingly detected
worldwide. Recently, coronavirus disease–associated pulmonary aspergillosis (CAPA) has …